Skip to content

Clinical outcomes of platelet-rich plasma and bone marrow aspirate concentrate on repair of rotator cuff tears

Clinical outcomes of the Synergistic Potential of PRP and BMAC on repair of large-sized tear

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN69088783
Enrollment
100
Registered
2024-08-27
Start date
2019-06-01
Completion date
Unknown
Last updated
2026-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Large (2-5 cm in width) chronic rotator cuff tear Injury, Occupational Diseases, Poisoning

Interventions

Patients will be randomly allocated to a control group, a bone marrow aspirate concentrate (BMAC)+platelet-rich plasma (PRP) group and a PRP-only group. Randomization will be performed using a predete

Sponsors

Hallym University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 72 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged at least 18 years 2. A large (2-5 cm in width) chronic rotator cuff tear confirmed by preoperative magnetic resonance imaging (MRI) 3. No history of shoulder surgery within the past 3 months 4. No abnormal findings on simple radiography, repair via arthroscopy 5. No abnormalities in blood coagulation or routine laboratory examination 6. No history of steroid injection within the past 3 months 7. No history of malignancy

Exclusion criteria

Exclusion criteria: 1. Subscapularis tendon disruptions (> 1/2 width) 2. Revision surgery 3. Inflammatory or autoimmune diseases 4. Reoperation due to re-tear 5. Other body parts operated within 6 months before and after rotator cuff repair 6. Any other associated shoulder lesion 7. Other severe medical problems, such as malignancy, respiratory disease, and preexisting coagulopathy 8. Positive urine pregnancy test in fertile women 9. Recent steroid injection within the past 3 months 10. Patients who refused to provide consent 11. Those who had difficulty partaking in clinical trials by the responsible investigator 12. Patients with cuff retraction or atrophy

Design outcomes

Primary

MeasureTime frame
1. Pain will be measured using the VAS at baseline (pre-surgery), 3 months and 6 months post-surgery . 2. Shoulder function will be measured using the ASES Shoulder Score at baseline (pre-surgery), 3 months and 6 months post-surgery. 3. Pain and ability to carry out normal daily activities will be measured using the constant score at baseline (pre-surgery), 3 months and 6 months post-surgery

Secondary

MeasureTime frame
1. MRI assessment of the supraspinatus, infraspinatous evaluates Muscle volume, Goutallier score of muscle atrophy and fatty infiltration at baseline (pre-surgery) and 6 months post-surgery. 2. Shoulder ultrasound examination evaluates rotator cuff tear size and lesion in millimeters at baseline (pre-surgery) and 3 weeks 3 months post-surgery

Countries

Korea, South

Contacts

Public ContactKyu-Cheol Noh
happyshoulder@hallym.or.kr+82-31-8086-2010

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 22, 2026